Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001181431-14-005260
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-05 16:56:49
Reporting Period:
2014-02-05
Filing Date:
2014-02-05
Accepted Time:
2014-02-05 16:56:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1567514 Intra-Cellular Therapies Inc. ITCI Pharmaceutical Preparations (2834) 364742850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1016835 B Rory Riggs C/o Intra-Cellular Therapies, Inc.
3960 Broadway
New York NY 10032
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-05 28,571 $17.50 240,955 No 4 P Indirect Held by New Ventures I, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Held by New Ventures I, LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 11,806 Direct
Footnotes
  1. Reflects shares purchased in the Issuer's public offering, which closed on February 5, 2014.
  2. Mr. Riggs is Managing Member of New Ventures I, LLC and may be deemed to beneficially own the securities held by New Ventures I, LLC. Mr. Riggs disclaims beneficial ownership of the securities held by New Ventures I, LLC except to the extent of his pecuniary interest therein.